|
SK287737B6
(sk)
|
1998-10-23 |
2011-08-04 |
Kirin-Amgen Inc. |
Peptidová zlúčenina, spôsob jej výroby a použitie, farmaceutický prostriedok, polynukleotid, vektor a hostiteľská bunka
|
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
US7205275B2
(en)
*
|
2001-10-11 |
2007-04-17 |
Amgen Inc. |
Methods of treatment using specific binding agents of human angiopoietin-2
|
|
CN100343304C
(zh)
|
2002-12-31 |
2007-10-17 |
尼克塔治疗亚拉巴马公司 |
水解稳定的马来酰亚胺封端的聚合物
|
|
US7432331B2
(en)
|
2002-12-31 |
2008-10-07 |
Nektar Therapeutics Al, Corporation |
Hydrolytically stable maleimide-terminated polymers
|
|
EP1648998B1
(en)
|
2003-07-18 |
2014-10-01 |
Amgen Inc. |
Specific binding agents to hepatocyte growth factor
|
|
US7605120B2
(en)
*
|
2003-10-22 |
2009-10-20 |
Amgen Inc. |
Antagonists of the brandykinin B1 receptor
|
|
RU2352583C2
(ru)
|
2003-11-13 |
2009-04-20 |
Ханми Фарм. Инд. Ко., Лтд. |
ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ Fc-ОБЛАСТЬ ИММУНОГЛОБУЛИНА В КАЧЕСТВЕ НОСИТЕЛЯ
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
US20060080092A1
(en)
*
|
2004-07-28 |
2006-04-13 |
Sherman Edward S |
Telecommunication device and method
|
|
CN101103045B
(zh)
*
|
2004-09-24 |
2015-11-25 |
安姆根有限公司 |
修饰的Fc分子
|
|
EP1909831A4
(en)
|
2005-06-14 |
2013-02-20 |
Amgen Inc |
SELF-BUFFING PROTEIN FORMULATIONS
|
|
WO2008020827A2
(en)
*
|
2005-08-01 |
2008-02-21 |
Biogen Idec Ma Inc. |
Altered polypeptides, immunoconjugates thereof, and methods related thereto
|
|
US8008453B2
(en)
*
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
ES2547421T3
(es)
*
|
2005-10-31 |
2015-10-06 |
Oncomed Pharmaceuticals, Inc. |
Composiciones y métodos para diagnosticar y tratar el cáncer
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
CA2633211A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Astrazeneca Ab |
Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer
|
|
AR059066A1
(es)
|
2006-01-27 |
2008-03-12 |
Amgen Inc |
Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf)
|
|
AR059193A1
(es)
*
|
2006-01-31 |
2008-03-12 |
Bayer Schering Pharma Ag |
Modulacion de la actividad de mdl-1 para el tratamiento de enfermedades inflamatorias
|
|
US7873029B2
(en)
*
|
2006-03-06 |
2011-01-18 |
At&T Intellectual Property I, L.P. |
System and method of providing multimedia communication services
|
|
US9283260B2
(en)
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
|
US7981425B2
(en)
*
|
2006-06-19 |
2011-07-19 |
Amgen Inc. |
Thrombopoietic compounds
|
|
US20090252703A1
(en)
*
|
2006-10-19 |
2009-10-08 |
Gegg Jr Colin V |
Use of alcohol co-solvents to improve pegylation reaction yields
|
|
PT2089425E
(pt)
*
|
2006-11-10 |
2011-10-17 |
Covx Technologies Ireland Ltd |
Compostos anti-angiogénicos
|
|
JP5591691B2
(ja)
|
2007-05-22 |
2014-09-17 |
アムジエン・インコーポレーテツド |
生物活性を有する融合タンパク質を作製するための組成物及び方法
|
|
PT2188313T
(pt)
|
2007-08-21 |
2017-12-12 |
Amgen Inc |
Proteínas de ligação ao antigénio c-fms humano
|
|
WO2009029795A1
(en)
*
|
2007-08-31 |
2009-03-05 |
Amgen Inc. |
Solid-state protein formulation
|
|
AU2008304111B2
(en)
|
2007-09-27 |
2014-04-24 |
Amgen Inc. |
Pharmaceutical formulations
|
|
EP3381445B1
(en)
|
2007-11-15 |
2023-10-25 |
Amgen Inc. |
Aqueous formulation of antibody stablised by antioxidants for parenteral administration
|
|
US20090162359A1
(en)
|
2007-12-21 |
2009-06-25 |
Christian Klein |
Bivalent, bispecific antibodies
|
|
US9266967B2
(en)
|
2007-12-21 |
2016-02-23 |
Hoffmann-La Roche, Inc. |
Bivalent, bispecific antibodies
|
|
US8557243B2
(en)
*
|
2008-01-03 |
2013-10-15 |
The Scripps Research Institute |
EFGR antibodies comprising modular recognition domains
|
|
EA201500156A3
(ru)
|
2008-01-03 |
2017-09-29 |
Дзе Скриппс Рисерч Инститьют |
Доставка антител посредством модульного домена распознавания
|
|
US8557242B2
(en)
*
|
2008-01-03 |
2013-10-15 |
The Scripps Research Institute |
ERBB2 antibodies comprising modular recognition domains
|
|
US8454960B2
(en)
*
|
2008-01-03 |
2013-06-04 |
The Scripps Research Institute |
Multispecific antibody targeting and multivalency through modular recognition domains
|
|
US8574577B2
(en)
*
|
2008-01-03 |
2013-11-05 |
The Scripps Research Institute |
VEGF antibodies comprising modular recognition domains
|
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
|
WO2009158432A2
(en)
|
2008-06-27 |
2009-12-30 |
Amgen Inc. |
Ang-2 inhibition to treat multiple sclerosis
|
|
SG190568A1
(en)
*
|
2008-09-26 |
2013-06-28 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
|
US8268314B2
(en)
|
2008-10-08 |
2012-09-18 |
Hoffmann-La Roche Inc. |
Bispecific anti-VEGF/anti-ANG-2 antibodies
|
|
US8133979B2
(en)
*
|
2008-12-16 |
2012-03-13 |
Hoffmann-La Roche Inc. |
Antibodies against human angiopoietin 2
|
|
US8734796B2
(en)
|
2009-03-20 |
2014-05-27 |
Amgen Inc. |
Carrier immunoglobulins
|
|
AU2010230563A1
(en)
|
2009-04-02 |
2011-09-22 |
Roche Glycart Ag |
Multispecific antibodies comprising full length antibodies and single chain Fab fragments
|
|
US20100256340A1
(en)
|
2009-04-07 |
2010-10-07 |
Ulrich Brinkmann |
Trivalent, bispecific antibodies
|
|
US9676845B2
(en)
|
2009-06-16 |
2017-06-13 |
Hoffmann-La Roche, Inc. |
Bispecific antigen binding proteins
|
|
CA2765881C
(en)
|
2009-06-22 |
2016-08-02 |
Joseph Edward Shultz |
Refolding proteins using a chemically controlled redox state
|
|
TWI513465B
(zh)
|
2009-06-25 |
2015-12-21 |
Regeneron Pharma |
以ｄｌｌ４拮抗劑與化學治療劑治療癌症之方法
|
|
EP3660032B1
(en)
|
2009-06-25 |
2025-10-22 |
Amgen Inc. |
Capture purification processes for proteins expressed in a non-mammalian system
|
|
JO3182B1
(ar)
|
2009-07-29 |
2018-03-08 |
Regeneron Pharma |
مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
|
|
US8980268B2
(en)
|
2009-07-29 |
2015-03-17 |
Regeneron Pharamceuticals, Inc. |
Methods for treating cancer by administering an anti-Ang-2 antibody
|
|
US20120189635A1
(en)
|
2009-07-29 |
2012-07-26 |
Regeneron Pharmaceuticals, Inc. |
Methods for Treating or Preventing Malaria by Administering an Antibody that Specifically Binds Angiopoietin-2 (Ang-2)
|
|
WO2011034605A2
(en)
|
2009-09-16 |
2011-03-24 |
Genentech, Inc. |
Coiled coil and/or tether containing protein complexes and uses thereof
|
|
US20120183546A1
(en)
*
|
2009-09-23 |
2012-07-19 |
Amgen Inc. |
Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
|
|
MX344382B
(es)
|
2009-10-23 |
2016-12-14 |
Amgen Inc * |
Adaptador de vial y sistema.
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
JO3183B1
(ar)
|
2010-01-29 |
2018-03-08 |
Regeneron Pharma |
طرق لمعالجة أمراض المناعة الذاتية مضادات dll4
|
|
AR080794A1
(es)
|
2010-03-26 |
2012-05-09 |
Hoffmann La Roche |
Anticuerpos bivalentes biespecificos anti- vegf/ anti-ang-2
|
|
AR080793A1
(es)
|
2010-03-26 |
2012-05-09 |
Roche Glycart Ag |
Anticuerpos biespecificos
|
|
NZ602700A
(en)
|
2010-04-01 |
2014-10-31 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
|
ES2617777T5
(es)
|
2010-04-23 |
2022-10-13 |
Hoffmann La Roche |
Producción de proteínas heteromultiméricas
|
|
US9061097B2
(en)
|
2010-06-07 |
2015-06-23 |
Amgen Inc. |
Drug delivery device
|
|
WO2012009705A1
(en)
|
2010-07-15 |
2012-01-19 |
Zyngenia, Inc. |
Ang-2 binding complexes and uses thereof
|
|
CN104474546A
(zh)
|
2010-08-13 |
2015-04-01 |
弗·哈夫曼-拉罗切有限公司 |
用于疾病治疗的针对IL-1β和IL-18的抗体
|
|
JP5758004B2
(ja)
|
2010-08-24 |
2015-08-05 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ジスルフィドによって安定化されたＦｖ断片を含む二重特異性抗体
|
|
US8993727B2
(en)
|
2010-09-22 |
2015-03-31 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
|
SG191153A1
(en)
|
2010-12-23 |
2013-07-31 |
Hoffmann La Roche |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
|
US10689447B2
(en)
|
2011-02-04 |
2020-06-23 |
Genentech, Inc. |
Fc variants and methods for their production
|
|
CN103649117B
(zh)
|
2011-02-04 |
2016-09-14 |
霍夫曼-拉罗奇有限公司 |
Fc变体及其生成方法
|
|
CA2827170A1
(en)
|
2011-02-11 |
2012-08-16 |
David M. Hilbert |
Monovalent and multivalent multispecific complexes and uses thereof
|
|
RU2013141078A
(ru)
|
2011-02-28 |
2015-04-10 |
Ф. Хоффманн-Ля Рош Аг |
Одновалентные антигенсвязывающие белки
|
|
BR112013019975A2
(pt)
|
2011-02-28 |
2017-08-01 |
Hoffmann La Roche |
proteínas de ligação de antígeno, composição farmacêutica, uso de uma proteína de ligação de antígeno, método para o tratamento de um paciente e método para a preparação de uma proteína de ligação de antígeno, ácido nucleico, vetor e célula hospedeira"
|
|
CA2831100C
(en)
|
2011-03-31 |
2020-02-18 |
Mark Dominis Holt |
Vial adapter and system
|
|
CA3021845C
(en)
|
2011-04-20 |
2022-03-29 |
Amgen Inc. |
Autoinjector apparatus
|
|
CN103857699B
(zh)
|
2011-05-24 |
2016-08-31 |
泽恩格尼亚股份有限公司 |
多价和单价多特异性复合物及其用途
|
|
AU2012272636A1
(en)
|
2011-06-24 |
2013-05-02 |
Advent Bio Holdings Llc |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
EP2726088B1
(en)
|
2011-06-29 |
2019-01-02 |
Amgen Inc. |
Predictive biomarker of survival in the treatment of renal cell carcinoma
|
|
US9605083B2
(en)
|
2011-08-16 |
2017-03-28 |
Emory University |
JAML specific binding agents, antibodies, and uses related thereto
|
|
BR112014008684B1
(pt)
|
2011-10-11 |
2021-11-09 |
Genentech, Inc |
Métodos de produção de proteínas heteromultiméricas e método de produção de anticorpo biespecífico
|
|
MX357209B
(es)
|
2011-10-14 |
2018-06-29 |
Amgen Inc |
Inyector y metodo de ensamble.
|
|
MX361039B
(es)
|
2011-10-26 |
2018-11-26 |
Amgen Inc |
Métodos para reducir o eliminar modificación de proteína y degradación que surge de la exposición a luz ultravioleta.
|
|
KR20140137347A
(ko)
|
2012-01-10 |
2014-12-02 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
|
|
WO2013112438A1
(en)
*
|
2012-01-23 |
2013-08-01 |
Regeneron Pharmaceuticals, Inc. |
Stabilized formulations containing anti-ang2 antibodies
|
|
JP6486686B2
(ja)
|
2012-02-10 |
2019-03-20 |
ジェネンテック， インコーポレイテッド |
単鎖抗体及び他のヘテロ多量体
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
CN110256567B
(zh)
|
2012-06-27 |
2023-04-25 |
弗·哈夫曼-拉罗切有限公司 |
用于选择并产生含有至少两种不同结合实体的定制靶向实体的方法及其用途
|
|
JP6309002B2
(ja)
|
2012-06-27 |
2018-04-11 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
標的に特異的に結合する少なくとも１つの結合実体を含む抗体Ｆｃ領域結合体を作製するための方法およびその使用
|
|
NZ702201A
(en)
|
2012-07-13 |
2018-01-26 |
Roche Glycart Ag |
Bispecific anti-vegf/anti-ang-2 antibodies and their use in the treatment of ocular vascular diseases
|
|
CA2880929A1
(en)
*
|
2012-09-07 |
2014-03-13 |
Sanofi |
Fusion proteins for treating a metabolic syndrome
|
|
KR101967345B1
(ko)
|
2012-10-18 |
2019-04-09 |
삼성전자주식회사 |
안지오포이에틴-2와 인테그린 간의 결합을 저해하는 펩타이드 및 그 용도
|
|
US9266959B2
(en)
|
2012-10-23 |
2016-02-23 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using frizzled-binding agents
|
|
AR093445A1
(es)
|
2012-11-14 |
2015-06-10 |
Regeneron Pharma |
Metodos para tratar el cancer de ovario con antagonistas de dll4
|
|
AU2013348071B2
(en)
|
2012-11-21 |
2018-05-24 |
Amgen Inc. |
Drug delivery device
|
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
|
HK1211887A1
(en)
|
2013-02-04 |
2016-06-03 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a wnt pathway inhibitor
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
|
JP6768501B2
(ja)
|
2013-03-15 |
2020-10-14 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入機、および自動注入機システム
|
|
BR112015022042B1
(pt)
|
2013-03-15 |
2023-01-10 |
Amgen Inc |
Injetor para injetar um produto terapêutico
|
|
EA201890895A1
(ru)
|
2013-03-15 |
2019-02-28 |
Зинджения, Инк. |
Мультивалентные и моновалентные мультиспецифические комплексы и их применение
|
|
AU2014238267B2
(en)
|
2013-03-22 |
2019-08-15 |
Amgen Inc. |
Injector and method of assembly
|
|
KR102131371B1
(ko)
|
2013-07-02 |
2020-07-08 |
삼성전자주식회사 |
Ang-2 특이적 항체 및 그의 용도
|
|
EP3381940B1
(en)
|
2013-07-29 |
2022-09-07 |
Samsung Electronics Co., Ltd. |
Anti-ang2 antibody
|
|
KR102196450B1
(ko)
|
2013-09-17 |
2020-12-30 |
삼성전자주식회사 |
Tie2와 결합을 유도하는 항 Ang2 항체를 포함하는 항암제
|
|
CA2922912A1
(en)
|
2013-10-11 |
2015-04-16 |
F. Hoffmann-La Roche Ag |
Multispecific domain exchanged common variable light chain antibodies
|
|
US10758683B2
(en)
|
2013-10-24 |
2020-09-01 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
|
EP3421066B1
(en)
|
2013-10-24 |
2021-03-03 |
Amgen Inc. |
Injector and method of assembly
|
|
WO2015090234A1
(en)
*
|
2013-12-19 |
2015-06-25 |
Beijing Anxinhuaide Biotech. Co., Ltd |
Improving pharmacokinetic profile for angiopoietin-2 inhibiting polypeptide or thymalfasin
|
|
KR102206029B1
(ko)
|
2014-01-27 |
2021-01-20 |
삼성전자주식회사 |
Ang-2에 특이적으로 결합하는 항체 및 그의 용도
|
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
HUE063273T2
(hu)
|
2014-05-06 |
2024-01-28 |
Hoffmann La Roche |
Heteromultimer fehérjék elõállítása emlõssejtek felhasználásával
|
|
CN106413779B
(zh)
|
2014-05-07 |
2020-06-05 |
安姆根有限公司 |
具有减震元件的自助注射器
|
|
AR100270A1
(es)
*
|
2014-05-19 |
2016-09-21 |
Lilly Co Eli |
Anticuerpos ang2
|
|
SG11201609970VA
(en)
|
2014-06-03 |
2016-12-29 |
Amgen Inc |
Systems and methods for remotely processing data collected by a drug delivery device
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
CA2957960C
(en)
|
2014-10-14 |
2023-08-22 |
Amgen, Inc. |
Drug injection device with visual and audible indicators
|
|
CN107001482B
(zh)
|
2014-12-03 |
2021-06-15 |
豪夫迈·罗氏有限公司 |
多特异性抗体
|
|
EP3233159B1
(en)
|
2014-12-19 |
2020-03-04 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
WO2016100781A1
(en)
|
2014-12-19 |
2016-06-23 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
AU2016220141B2
(en)
|
2015-02-17 |
2018-07-12 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
EP3981450A1
(en)
|
2015-02-27 |
2022-04-13 |
Amgen, Inc |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
WO2016176427A1
(en)
|
2015-04-30 |
2016-11-03 |
Amgen Inc. |
Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
WO2016209972A1
(en)
|
2015-06-26 |
2016-12-29 |
Amgen Inc. |
Biomarker of survival in the treatment of renal cell carcinoma with a vegfr inhibitor and an ang2 inhibitor
|
|
SG10202101105XA
(en)
|
2015-08-13 |
2021-03-30 |
Amgen Inc |
Charged depth filtration of antigen-binding proteins
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
JP7372036B2
(ja)
*
|
2016-03-03 |
2023-10-31 |
キュー バイオファーマ， インコーポレイテッド |
Ｔ細胞調節多量体ポリペプチド及びその使用方法
|
|
WO2017157990A1
(en)
*
|
2016-03-15 |
2017-09-21 |
Idp Discovery Pharma, S.L. |
Peptides with anti-cancer activity
|
|
EP4035711B1
(en)
|
2016-03-15 |
2025-06-04 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
MX2018013616A
(es)
|
2016-05-13 |
2019-02-21 |
Amgen Inc |
Montaje de cubierta protectora de vial.
|
|
WO2017197199A1
(en)
*
|
2016-05-13 |
2017-11-16 |
Askgene Pharma Inc. |
Novel angiopoietin 2, vegf dual antagonists
|
|
US11059885B2
(en)
*
|
2016-05-13 |
2021-07-13 |
Askgene Pharma Inc. |
Angiopoietin 2, VEGF dual antagonists
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
US11285266B2
(en)
|
2016-07-01 |
2022-03-29 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
ES2973548T3
(es)
|
2016-12-22 |
2024-06-20 |
Cue Biopharma Inc |
Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso
|
|
US10537637B2
(en)
|
2017-01-05 |
2020-01-21 |
Gensun Biopharma Inc. |
Checkpoint regulator antagonists
|
|
JP2020503976A
(ja)
|
2017-01-17 |
2020-02-06 |
アムジエン・インコーポレーテツド |
注入デバイスならびに関連する使用および組立方法
|
|
WO2018152073A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
EP3582825A1
(en)
|
2017-02-17 |
2019-12-25 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
MX2019010544A
(es)
|
2017-03-06 |
2019-10-21 |
Amgen Inc |
Dispositivo de administracion de farmacos con caracteristica de prevencion de la activacion.
|
|
IL268478B2
(en)
|
2017-03-07 |
2023-10-01 |
Amgen Inc |
Inserting a needle using super pressure
|
|
EP3592404A1
(en)
|
2017-03-09 |
2020-01-15 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
KR102517342B1
(ko)
|
2017-03-28 |
2023-03-31 |
암겐 인코포레이티드 |
플런저 로드 및 주사기 조립 시스템 및 방법
|
|
WO2018226565A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Torque driven drug delivery device
|
|
WO2018226515A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
US11541183B2
(en)
|
2017-06-22 |
2023-01-03 |
Amgen Inc. |
Device activation impact/shock reduction
|
|
MA49461A
(fr)
|
2017-06-23 |
2020-04-29 |
Amgen Inc |
Dispositif électronique d'administration de médicament comprenant un bouchon activé par un ensemble commutateur
|
|
IL270784B2
(en)
|
2017-07-14 |
2023-11-01 |
Amgen Inc |
Needle insertion-extraction system with a double torsion spring system
|
|
WO2019018169A1
(en)
|
2017-07-21 |
2019-01-24 |
Amgen Inc. |
PERMEABLE GAS SEALING ELEMENT FOR MEDICINE CONTAINER AND METHODS OF ASSEMBLY
|
|
JP7242562B2
(ja)
|
2017-07-25 |
2023-03-20 |
アムジエン・インコーポレーテツド |
容器アクセスシステムを有する薬物送達デバイス及び関連する組立方法
|
|
EP4085942A1
(en)
|
2017-07-25 |
2022-11-09 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
US12318593B2
(en)
|
2017-08-09 |
2025-06-03 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
|
WO2019036181A1
(en)
|
2017-08-18 |
2019-02-21 |
Amgen Inc. |
BODY INJECTOR WITH STERILE ADHESIVE PATCH
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
US11813426B2
(en)
|
2017-10-06 |
2023-11-14 |
Amgen Inc. |
Drug delivery device including seal member for needle of syringe
|
|
MA50348A
(fr)
|
2017-10-09 |
2020-08-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
|
|
MA50527A
(fr)
|
2017-11-03 |
2020-09-09 |
Amgen Inc |
Système et approches pour stériliser un dispositif d'administration de médicament
|
|
US12053618B2
(en)
|
2017-11-06 |
2024-08-06 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
|
JP2021501616A
(ja)
|
2017-11-06 |
2021-01-21 |
アムジエン・インコーポレーテツド |
配置及び流量検出を備える薬物送達デバイス
|
|
MX2020004736A
(es)
|
2017-11-10 |
2020-08-13 |
Amgen Inc |
Embolos para dispositivos de administracion de farmacos.
|
|
JP7370969B2
(ja)
|
2017-11-16 |
2023-10-30 |
アムジエン・インコーポレーテツド |
薬物送達デバイスの扉ラッチ機構
|
|
WO2019099322A1
(en)
|
2017-11-16 |
2019-05-23 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
US10647773B2
(en)
|
2018-06-29 |
2020-05-12 |
Gensun Biopharma, Inc. |
Trispecific antagonists
|
|
MX2021000748A
(es)
|
2018-07-24 |
2021-03-26 |
Amgen Inc |
Dispositivos de suministro para administrar farmacos.
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
WO2020028009A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
US20210346601A1
(en)
|
2018-09-24 |
2021-11-11 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
MA53718A
(fr)
|
2018-09-28 |
2022-01-05 |
Amgen Inc |
Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament
|
|
CA3110529A1
(en)
|
2018-10-02 |
2020-04-09 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
TW202529830A
(zh)
|
2018-10-05 |
2025-08-01 |
美商安進公司 |
具有劑量指示器之藥物遞送裝置
|
|
EP3866889A1
(en)
|
2018-10-15 |
2021-08-25 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
|
EP3866890A1
(en)
|
2018-10-15 |
2021-08-25 |
Amgen Inc. |
Drug delivery device having damping mechanism
|
|
SI3870957T1
(sl)
|
2018-10-23 |
2025-10-30 |
Amgen Inc. |
Avtomatska kalibracija in avtomatsko vzdrževanje spektroskopskih modelov za napovedovanje v realnem času
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
ES3010833T3
(en)
|
2018-11-01 |
2025-04-04 |
Amgen Inc |
Drug delivery devices with partial drug delivery member retraction
|
|
EP3873563A1
(en)
|
2018-11-01 |
2021-09-08 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
ES3032751T3
(en)
|
2019-04-24 |
2025-07-24 |
Amgen Inc |
Syringe sterilization verification assemblies and methods
|
|
KR102400401B1
(ko)
*
|
2019-05-22 |
2022-05-24 |
(주)셀인바이오 |
항염증 펩타이드 및 항염증 조성물
|
|
CN114340735B
(zh)
|
2019-06-28 |
2024-11-12 |
璟尚生物制药公司 |
突变的TGFβ1-RII胞外域和免疫球蛋白支架组成的抗肿瘤拮抗剂
|
|
JP7608439B2
(ja)
|
2019-08-23 |
2025-01-06 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
|
KR102312922B1
(ko)
*
|
2019-11-19 |
2021-10-13 |
삼성전자주식회사 |
Tie2와 결합을 유도하는 항 Ang2 항체
|
|
KR102195957B1
(ko)
*
|
2019-11-19 |
2020-12-28 |
삼성전자주식회사 |
Tie2와 결합을 유도하는 항 Ang2 항체
|
|
US20230071627A1
(en)
|
2020-02-03 |
2023-03-09 |
Amgen Inc. |
Multivariate Bracketing Approach for Sterile Filter Validation
|
|
WO2021222762A2
(en)
*
|
2020-04-30 |
2021-11-04 |
Aetio Biotherapy, Inc. |
Activatable il2 composition and methods of use
|
|
EP4149534A4
(en)
|
2020-05-12 |
2024-09-04 |
Cue Biopharma, Inc. |
MULTIMERIC POLYPEPTIDES MODULATING T CELLS AND METHODS OF USE THEREOF
|
|
CN112126671B
(zh)
*
|
2020-08-18 |
2021-08-31 |
中山大学附属第五医院 |
无乳链球菌Streptococus agalactiae治疗子宫内膜异位症的应用
|
|
AU2021326709B2
(en)
*
|
2020-08-19 |
2025-06-26 |
Pharmabcine Inc. |
Modified antibody and method for manufacturing same
|
|
CN116981470A
(zh)
*
|
2021-03-19 |
2023-10-31 |
Cue生物制药股份有限公司 |
T细胞调节多肽和其使用方法
|
|
JP2024514072A
(ja)
*
|
2021-03-31 |
2024-03-28 |
ハングズホウ エクセジェネシス バイオ エルティーディー． |
Ｖｅｇｆ及びアンジオポエチンを標的とする融合分子及びその使用
|
|
BR112023024278A2
(pt)
|
2021-05-21 |
2024-01-30 |
Amgen Inc |
Método de otimizar uma receita de enchimento para um recipiente de fármacos
|
|
WO2022256820A1
(en)
|
2021-06-03 |
2022-12-08 |
Gensun Biopharma Inc. |
Multispecific antagonists
|
|
AR127458A1
(es)
|
2021-10-27 |
2024-01-24 |
Amgen Inc |
Predicción basada en aprendizaje profundo usando espectroscopia
|
|
EP4490202A1
(en)
|
2022-03-11 |
2025-01-15 |
University of Rochester |
Cyclopeptibodies and uses thereof
|
|
JP2025534759A
(ja)
*
|
2022-10-18 |
2025-10-17 |
クロスポイント セラピューティクス インコーポレイテッド |
ヒト抗体ｆｃドメイン変異体及びその用途
|
|
WO2025037108A2
(en)
|
2023-08-15 |
2025-02-20 |
Board Of Trustees Of The Leland Stanford Junior University |
Modified thrombopoietin
|
|
WO2025237264A1
(en)
*
|
2024-05-14 |
2025-11-20 |
Shanghai Affamed Therapeutics Limited |
A method for treating retinal and choroidal vascular diseases with a chimeric molecule
|